317 related articles for article (PubMed ID: 34207868)
1. Common Polymorphisms in the Glycoproteins of Human Cytomegalovirus and Associated Strain-Specific Immunity.
Wang HY; Valencia SM; Pfeifer SP; Jensen JD; Kowalik TF; Permar SR
Viruses; 2021 Jun; 13(6):. PubMed ID: 34207868
[TBL] [Abstract][Full Text] [Related]
2. A Novel Strain-Specific Neutralizing Epitope on Glycoprotein H of Human Cytomegalovirus.
Thomas M; Kropff B; Schneider A; Winkler TH; Görzer I; Sticht H; Britt WJ; Mach M; Reuter N
J Virol; 2021 Aug; 95(18):e0065721. PubMed ID: 34160252
[TBL] [Abstract][Full Text] [Related]
3. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
Chiuppesi F; Nguyen J; Park S; Contreras H; Kha M; Meng Z; Kaltcheva T; Iniguez A; Martinez J; La Rosa C; Wussow F; Diamond DJ
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045984
[TBL] [Abstract][Full Text] [Related]
4. Glycoprotein N of human cytomegalovirus protects the virus from neutralizing antibodies.
Kropff B; Burkhardt C; Schott J; Nentwich J; Fisch T; Britt W; Mach M
PLoS Pathog; 2012; 8(10):e1002999. PubMed ID: 23133379
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex.
Ha S; Li F; Troutman MC; Freed DC; Tang A; Loughney JW; Wang D; Wang IM; Vlasak J; Nickle DC; Rustandi RR; Hamm M; DePhillips PA; Zhang N; McLellan JS; Zhu H; Adler SP; McVoy MA; An Z; Fu TM
J Virol; 2017 Apr; 91(7):. PubMed ID: 28077654
[TBL] [Abstract][Full Text] [Related]
6. Intrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees.
Nelson CS; Vera Cruz D; Su M; Xie G; Vandergrift N; Pass RF; Forman M; Diener-West M; Koelle K; Arav-Boger R; Permar SR
J Virol; 2019 Mar; 93(5):. PubMed ID: 30518646
[TBL] [Abstract][Full Text] [Related]
7. Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine.
Freed DC; Tang Q; Tang A; Li F; He X; Huang Z; Meng W; Xia L; Finnefrock AC; Durr E; Espeseth AS; Casimiro DR; Zhang N; Shiver JW; Wang D; An Z; Fu TM
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):E4997-5005. PubMed ID: 24297878
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in Human Cytomegalovirus Glycoprotein O (gO) Exert Epistatic Influences on Cell-Free and Cell-to-Cell Spread and Antibody Neutralization on gH Epitopes.
Day LZ; Stegmann C; Schultz EP; Lanchy JM; Yu Q; Ryckman BJ
J Virol; 2020 Mar; 94(8):. PubMed ID: 31996433
[TBL] [Abstract][Full Text] [Related]
9. Soluble Human Cytomegalovirus gH/gL/pUL128-131 Pentameric Complex, but Not gH/gL, Inhibits Viral Entry to Epithelial Cells and Presents Dominant Native Neutralizing Epitopes.
Loughney JW; Rustandi RR; Wang D; Troutman MC; Dick LW; Li G; Liu Z; Li F; Freed DC; Price CE; Hoang VM; Culp TD; DePhillips PA; Fu TM; Ha S
J Biol Chem; 2015 Jun; 290(26):15985-95. PubMed ID: 25947373
[TBL] [Abstract][Full Text] [Related]
10. Recognition of a highly conserved glycoprotein B epitope by a bivalent antibody neutralizing HCMV at a post-attachment step.
Ye X; Su H; Wrapp D; Freed DC; Li F; Yuan Z; Tang A; Li L; Ku Z; Xiong W; Jaijyan D; Zhu H; Wang D; McLellan JS; Zhang N; Fu TM; An Z
PLoS Pathog; 2020 Aug; 16(8):e1008736. PubMed ID: 32745149
[TBL] [Abstract][Full Text] [Related]
11. Strain-specific neutralizing antibody responses against human cytomegalovirus envelope glycoprotein N.
Pati SK; Novak Z; Purser M; Arora N; Mach M; Britt WJ; Boppana SB
Clin Vaccine Immunol; 2012 Jun; 19(6):909-13. PubMed ID: 22492744
[TBL] [Abstract][Full Text] [Related]
12. Antibodies against neutralization epitopes of human cytomegalovirus gH/gL/pUL128-130-131 complex and virus spreading may correlate with virus control in vivo.
Lilleri D; Kabanova A; Lanzavecchia A; Gerna G
J Clin Immunol; 2012 Dec; 32(6):1324-31. PubMed ID: 22836657
[TBL] [Abstract][Full Text] [Related]
13. Neutralization of rhesus cytomegalovirus IL-10 reduces horizontal transmission and alters long-term immunity.
Deere JD; Chang WLW; Villalobos A; Schmidt KA; Deshpande A; Castillo LD; Fike J; Walter MR; Barry PA; Hartigan-O'Connor DJ
Proc Natl Acad Sci U S A; 2019 Jun; 116(26):13036-13041. PubMed ID: 31189602
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation.
Gerna G; Percivalle E; Perez L; Lanzavecchia A; Lilleri D
J Virol; 2016 Jul; 90(14):6216-6223. PubMed ID: 27122579
[TBL] [Abstract][Full Text] [Related]
15. Human cytomegalovirus infection elicits a glycoprotein M (gM)/gN-specific virus-neutralizing antibody response.
Shimamura M; Mach M; Britt WJ
J Virol; 2006 May; 80(9):4591-600. PubMed ID: 16611919
[TBL] [Abstract][Full Text] [Related]
16. Specificity and effector functions of non-neutralizing gB-specific monoclonal antibodies isolated from healthy individuals with human cytomegalovirus infection.
Goodwin ML; Webster HS; Wang HY; Jenks JA; Nelson CS; Tu JJ; Mangold JF; Valencia S; Pollara J; Edwards W; McLellan JS; Wrapp D; Fu TM; Zhang N; Freed DC; Wang D; An Z; Permar SR
Virology; 2020 Sep; 548():182-191. PubMed ID: 32838941
[TBL] [Abstract][Full Text] [Related]
17. Production of Cytomegalovirus Dense Bodies by Scalable Bioprocess Methods Maintains Immunogenicity and Improves Neutralizing Antibody Titers.
Schneider-Ohrum K; Cayatte C; Liu Y; Wang Z; Irrinki A; Cataniag F; Nguyen N; Lambert S; Liu H; Aslam S; Duke G; McCarthy MP; McCormick L
J Virol; 2016 Nov; 90(22):10133-10144. PubMed ID: 27581989
[TBL] [Abstract][Full Text] [Related]
18. Dense Bodies of a gH/gL/UL128/UL130/UL131 Pentamer-Repaired Towne Strain of Human Cytomegalovirus Induce an Enhanced Neutralizing Antibody Response.
Lehmann C; Falk JJ; Büscher N; Penner I; Zimmermann C; Gogesch P; Sinzger C; Plachter B
J Virol; 2019 Sep; 93(17):. PubMed ID: 31189713
[TBL] [Abstract][Full Text] [Related]
19. Strain-specific neutralization of human cytomegalovirus isolates by human sera.
Klein M; Schoppel K; Amvrossiadis N; Mach M
J Virol; 1999 Feb; 73(2):878-86. PubMed ID: 9882288
[TBL] [Abstract][Full Text] [Related]
20. Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex.
Wussow F; Chiuppesi F; Martinez J; Campo J; Johnson E; Flechsig C; Newell M; Tran E; Ortiz J; La Rosa C; Herrmann A; Longmate J; Chakraborty R; Barry PA; Diamond DJ
PLoS Pathog; 2014 Nov; 10(11):e1004524. PubMed ID: 25412505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
